Literature DB >> 21774970

Distribution of sugar residues in human placentas from pregnancies complicated by hypertensive disorders.

Mirca Marini1, Laura Bonaccini, Giorgia Donata Zappoli Thyrion, Debora Vichi, Elena Parretti, Eleonora Sgambati.   

Abstract

The aim of the study was to investigate the content and distribution of sugar residues in placentas from pregnancies complicated by hypertensive disorders. Placentas from women with uncomplicated pregnancies (group 1), pregnancies complicated by gestational hypertension (group 2), pregnancies complicated by pre-eclampsia (group 3), pregnancies complicated by pre-eclampsia with HELLP syndrome (hemolysis, elevated liver enzymes and low platelets) (group 4) were collected. Lectins: ConA, WGA, PNA, SBA, DBA, UEA I, GNA, DSA, MAA, SNA, in combination with chemical and enzymatic treatments, were used. Data showed a decrease and/or lack of α-d-mannose, α-d-glucose and d-galactose-(β1-4)-N-acetyl-d-glucosamine in placentas from pre-eclampsia and pre-eclampsia with HELLP syndrome compared with control and hypertension cases. N-acetyl-d-galactosamine appeared and/or increased in placentas from hypertensive disorders. A different distribution of various types of sialic acid was observed in placentas from hypertensive disorders compared with the controls. In particular, placentas from pre-eclampsia, with and without HELLP syndrome, lacked the acetylated sialic acid side-chain. These findings demonstrate various alterations of the carbohydrate metabolism in the placentas from pregnancies complicated by different types of hypertensive disorders. This indicates correlation with the placental morpho-functional changes characteristic of these complications and with the degree of clinical severity. Copyright Â
© 2010 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774970     DOI: 10.1016/j.acthis.2010.12.001

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  7 in total

1.  Comparative Characteristics of Sialoglycans Expression Disorders in the Placental Barrier Structures in Preeclampsia and Fetal Growth Restriction.

Authors:  M M Ziganshina; G V Kulikova; A I Shchegolev; R G Shmakov; N E Kan; G T Sukhikh
Journal:  Bull Exp Biol Med       Date:  2022-06-24       Impact factor: 0.804

Review 2.  Functional glycosylation in the human and mammalian uterus.

Authors:  Gary F Clark
Journal:  Fertil Res Pract       Date:  2015-10-23

Review 3.  Can Endothelial Glycocalyx Be a Major Morphological Substrate in Pre-Eclampsia?

Authors:  Marina M Ziganshina; Ekaterina L Yarotskaya; Nicolai V Bovin; Stanislav V Pavlovich; Gennady T Sukhikh
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

Review 4.  Pregnancy Galectinology: Insights Into a Complex Network of Glycan Binding Proteins.

Authors:  Sandra M Blois; Gabriela Dveksler; Gerardo R Vasta; Nancy Freitag; Véronique Blanchard; Gabriela Barrientos
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

Review 5.  The Immunology of Syncytialized Trophoblast.

Authors:  Danny J Schust; Elizabeth A Bonney; Jun Sugimoto; Toshi Ezashi; R Michael Roberts; Sehee Choi; Jie Zhou
Journal:  Int J Mol Sci       Date:  2021-02-10       Impact factor: 6.208

6.  Correlation between Sialylation Status and Cell Susceptibility to Amyloid Toxicity.

Authors:  Eleonora Sgambati; Alessia Tani; Manuela Leri; Giovanni Delfino; Sandra Zecchi-Orlandini; Monica Bucciantini; Daniele Nosi
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

7.  Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics.

Authors:  Sophia Borowski; Irene Tirado-Gonzalez; Nancy Freitag; Mariana G Garcia; Gabriela Barrientos; Sandra M Blois
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.